Cellectis S.A. | Mutual Funds
Mutual Funds that own Cellectis S.A.
Government Pension Fund - Global (The)
279,000
0.66%
-43,000
0%
12/31/2017
Baillie Gifford Overseas Growth Fund - Global Discovery Fund
260,752
0.62%
16,112
1.15%
04/30/2018
Old Westbury Small & Mid Cap Fund
252,897
0.6%
123,700
0.11%
04/30/2018
Edinburgh Worldwide Investment Trust Plc
190,310
0.45%
0
0.9%
10/31/2017
Baillie Gifford Overseas Growth Fund - European Fund
173,509
0.41%
0
0.89%
04/30/2018
HBM BioVentures Ltd.
143,390
0.34%
143,390
0.28%
12/31/2017
MGI Funds Plc - Mercer Global Small Cap Equity Fund
142,708
0.34%
142,708
0.28%
06/30/2017
iShares Core MSCI EAFE ETF
131,005
0.31%
0
0.01%
09/06/2018
iShares MSCI EAFE Small Cap ETF
128,958
0.31%
0
0.04%
09/06/2018
Acatis Datini Valueflex Fonds
120,274
0.28%
2,324
1.03%
06/29/2018
| Address |
8, rue de la Croix Jarry
Paris Ile-de-France 75013
France
|
|
Employees
|
- |
| Website |
http://www.cellectis.com |
| Updated |
07/08/2019 |
| Cellectis SA is a biopharmaceutical company, which engages in the research and development of genome engineering technology. The company operates through the following business segments: Therapeutics and Plants. The Therapeutics segment is focused on the development of products in the field of immune-oncology and of novel products outside immuno-oncology to treat other human diseases. |
